Julian Collins
Vice President of Sales, Intra-Cellular Therapies
Professional Overview
Julian Collins is an accomplished sales and commercial strategy executive with extensive experience in the pharmaceutical and biotech industries. As the Vice President of Sales at Intra-Cellular Therapies, he leverages his deep industry knowledge and proven leadership to drive commercial success and sustainable growth.
Experience Summary
Current Role
As the Vice President of Sales at Intra-Cellular Therapies, Julian is responsible for leading the company's sales initiatives and overseeing the commercial strategy for its portfolio of innovative pharmaceutical products. He has played a pivotal role in expanding the company's market reach and driving revenue growth, contributing to its position as a prominent player in the industry.
Career Progression
Prior to his current role, Julian held various leadership positions at leading pharmaceutical and biotech companies. He served as the Executive Director of Commercial Strategy at Pfizer and Seagen, where he was instrumental in developing and implementing successful commercial strategies that enhanced product performance and market share. Additionally, he held roles as the National Sales Director for Hematology at Seagen and the Regional Oncology Business Director at Johnson & Johnson, demonstrating his versatility and breadth of experience in the sector.
Academic Background
Julian holds a Bachelor of Science degree in Biological Sciences from the University of Texas, where he graduated with honors.
Areas of Expertise
- Strategic sales and commercial planning
- Pharmaceutical and biotech industry knowledge
- New product launch and commercialization
- Data-driven decision making
- Cross-functional team leadership and collaboration
Professional Impact
Throughout his career, Julian has consistently demonstrated his ability to drive measurable results and make a significant impact on the organizations he has served. His achievements include:
- Spearheading the successful launch of a new oncology product at Seagen, resulting in a 25% increase in market share within the first year
- Implementing a comprehensive sales training program at Pfizer that improved sales team effectiveness and productivity by 18%
- Developing and executing innovative marketing campaigns that contributed to a 15% year-over-year revenue growth for a key hematology product at Johnson & Johnson
Conclusion
With his extensive industry experience, strategic acumen, and proven track record of success, Julian Collins is positioned to make a significant impact in his role as the Vice President of Sales at Intra-Cellular Therapies. His dedication to driving commercial excellence and delivering tangible results aligns with the company's mission to improve patient outcomes and advance the pharmaceutical industry.
